Your browser doesn't support javascript.
loading
Bespoke library docking for 5-HT2A receptor agonists with antidepressant activity.
Kaplan, Anat Levit; Confair, Danielle N; Kim, Kuglae; Barros-Álvarez, Ximena; Rodriguiz, Ramona M; Yang, Ying; Kweon, Oh Sang; Che, Tao; McCorvy, John D; Kamber, David N; Phelan, James P; Martins, Luan Carvalho; Pogorelov, Vladimir M; DiBerto, Jeffrey F; Slocum, Samuel T; Huang, Xi-Ping; Kumar, Jain Manish; Robertson, Michael J; Panova, Ouliana; Seven, Alpay B; Wetsel, Autumn Q; Wetsel, William C; Irwin, John J; Skiniotis, Georgios; Shoichet, Brian K; Roth, Bryan L; Ellman, Jonathan A.
Afiliação
  • Kaplan AL; Department of Pharmaceutical Chemistry, University of California, San Francisco, CA, USA.
  • Confair DN; Department of Chemistry, Yale University, New Haven, CT, USA.
  • Kim K; Department of Pharmacology, University of North Carolina, Chapel Hill School of Medicine, Chapel Hill, NC, USA.
  • Barros-Álvarez X; Department of Pharmacy, Yonsei University, Incheon, Republic of Korea.
  • Rodriguiz RM; Department of Molecular and Cellular Physiology, Stanford University School of Medicine, Stanford, CA, USA.
  • Yang Y; Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, NC, USA.
  • Kweon OS; Mouse Behavioral and Neuroendocrine Analysis Core Facility, Duke University Medical Center, Durham, NC, USA.
  • Che T; Department of Pharmaceutical Chemistry, University of California, San Francisco, CA, USA.
  • McCorvy JD; Department of Chemistry, Yale University, New Haven, CT, USA.
  • Kamber DN; Center for Clinical Pharmacology, Department of Anesthesiology, Washington University School of Medicine, St Louis, MO, USA.
  • Phelan JP; Department of Cell Biology, Neurobiology and Anatomy, Medical College of Wisconsin, Milwaukee, WI, USA.
  • Martins LC; Department of Chemistry, Yale University, New Haven, CT, USA.
  • Pogorelov VM; Department of Chemistry, Yale University, New Haven, CT, USA.
  • DiBerto JF; Department of Pharmaceutical Chemistry, University of California, San Francisco, CA, USA.
  • Slocum ST; Biochemistry Department, Institute for Biological Sciences, Federal University of Minas Gerais, Belo Horizonte, Brazil.
  • Huang XP; Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, NC, USA.
  • Kumar JM; Department of Pharmacology, University of North Carolina, Chapel Hill School of Medicine, Chapel Hill, NC, USA.
  • Robertson MJ; Department of Pharmacology, University of North Carolina, Chapel Hill School of Medicine, Chapel Hill, NC, USA.
  • Panova O; National Institute of Mental Health Psychoactive Drug Screening Program, University of North Carolina Chapel Hill School of Medicine, Chapel Hill, NC, USA.
  • Seven AB; Department of Pharmacology, University of North Carolina, Chapel Hill School of Medicine, Chapel Hill, NC, USA.
  • Wetsel AQ; Department of Molecular and Cellular Physiology, Stanford University School of Medicine, Stanford, CA, USA.
  • Wetsel WC; Department of Molecular and Cellular Physiology, Stanford University School of Medicine, Stanford, CA, USA.
  • Irwin JJ; Department of Molecular and Cellular Physiology, Stanford University School of Medicine, Stanford, CA, USA.
  • Skiniotis G; Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, NC, USA.
  • Shoichet BK; Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, NC, USA. william.wetsel@duke.edu.
  • Roth BL; Mouse Behavioral and Neuroendocrine Analysis Core Facility, Duke University Medical Center, Durham, NC, USA. william.wetsel@duke.edu.
  • Ellman JA; Department of Cell Biology, Duke University Medical Center, Durham, NC, USA. william.wetsel@duke.edu.
Nature ; 610(7932): 582-591, 2022 10.
Article em En | MEDLINE | ID: mdl-36171289
ABSTRACT
There is considerable interest in screening ultralarge chemical libraries for ligand discovery, both empirically and computationally1-4. Efforts have focused on readily synthesizable molecules, inevitably leaving many chemotypes unexplored. Here we investigate structure-based docking of a bespoke virtual library of tetrahydropyridines-a scaffold that is poorly sampled by a general billion-molecule virtual library but is well suited to many aminergic G-protein-coupled receptors. Using three inputs, each with diverse available derivatives, a one pot C-H alkenylation, electrocyclization and reduction provides the tetrahydropyridine core with up to six sites of derivatization5-7. Docking a virtual library of 75 million tetrahydropyridines against a model of the serotonin 5-HT2A receptor (5-HT2AR) led to the synthesis and testing of 17 initial molecules. Four of these molecules had low-micromolar activities against either the 5-HT2A or the 5-HT2B receptors. Structure-based optimization led to the 5-HT2AR agonists (R)-69 and (R)-70, with half-maximal effective concentration values of 41 nM and 110 nM, respectively, and unusual signalling kinetics that differ from psychedelic 5-HT2AR agonists. Cryo-electron microscopy structural analysis confirmed the predicted binding mode to 5-HT2AR. The favourable physical properties of these new agonists conferred high brain permeability, enabling mouse behavioural assays. Notably, neither had psychedelic activity, in contrast to classic 5-HT2AR agonists, whereas both had potent antidepressant activity in mouse models and had the same efficacy as antidepressants such as fluoxetine at as low as 1/40th of the dose. Prospects for using bespoke virtual libraries to sample pharmacologically relevant chemical space will be considered.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pirrolidinas / Receptor 5-HT2A de Serotonina / Antidepressivos Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: Nature Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pirrolidinas / Receptor 5-HT2A de Serotonina / Antidepressivos Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: Nature Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos